BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 27730528)

  • 21. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
    Jakesz R; Jonat W; Gnant M; Mittlboeck M; Greil R; Tausch C; Hilfrich J; Kwasny W; Menzel C; Samonigg H; Seifert M; Gademann G; Kaufmann M; Wolfgang J;
    Lancet; 2005 Aug 6-12; 366(9484):455-62. PubMed ID: 16084253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An International Menopause Society study of climate, altitude, temperature (IMS-CAT) and vasomotor symptoms in urban Indian regions.
    Stefanopoulou E; Shah D; Shah R; Gupta P; Sturdee DW; Hunter MS
    Climacteric; 2014 Aug; 17(4):417-24. PubMed ID: 24099134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms.
    Lampio L; Polo-Kantola P; Polo O; Kauko T; Aittokallio J; Saaresranta T
    Menopause; 2014 Nov; 21(11):1217-24. PubMed ID: 24755900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Muka T; Oliver-Williams C; Colpani V; Kunutsor S; Chowdhury S; Chowdhury R; Kavousi M; Franco OH
    PLoS One; 2016; 11(6):e0157417. PubMed ID: 27315068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
    McCaig FM; Renshaw L; Williams L; Young O; Murray J; Macaskill EJ; McHugh M; Hannon R; Dixon JM
    Breast Cancer Res Treat; 2010 Feb; 119(3):643-51. PubMed ID: 19941160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMS study of climate, altitude, temperature and vasomotor symptoms in the United Arab Emirates.
    Stefanopoulou E; Gupta P; Mostafa RM; Nosair N; Mirghani Z; Moustafa K; Al Kusayer G; Sturdee DW; Hunter MS
    Climacteric; 2014 Aug; 17(4):425-32. PubMed ID: 24625187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.
    Chen Y; Dorjgochoo T; Bao PP; Zheng Y; Cai H; Lu W; Shu XO
    PLoS One; 2013; 8(9):e75926. PubMed ID: 24098745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
    Mohammady M; Janani L; Jahanfar S; Mousavi MS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study.
    Zeleke BM; Bell RJ; Billah B; Davis SR
    Fertil Steril; 2016 Jan; 105(1):149-55.e1. PubMed ID: 26450529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of Serum Estradiol and Duration of Anastrazole Therapy with Treatment Related Adverse Effects Among Postmenopausal Breast Cancer Women: A Cross-sectional Study.
    Abubakar MB; Gan SH
    Niger J Physiol Sci; 2017 Dec; 32(2):219-225. PubMed ID: 29485645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women.
    Glusman JE; Huster WJ; Paul S
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):166. PubMed ID: 10838311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
    Williams RE; Kalilani L; DiBenedetti DB; Zhou X; Granger AL; Fehnel SE; Levine KB; Jordan J; Clark RV
    Climacteric; 2008 Feb; 11(1):32-43. PubMed ID: 18202963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer.
    Sendur MA; Aksoy S; Zengin N; Altundag K
    J BUON; 2013; 18(4):838-44. PubMed ID: 24344006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual function after breast cancer.
    Panjari M; Bell RJ; Davis SR
    J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint symptoms: a practical problem of anastrozole.
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O; Sakamoto N
    Breast Cancer; 2006; 13(3):284-288. PubMed ID: 16929123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
    Okishiro M; Taguchi T; Kim SJ; Tanji Y; Shimazu K; Tamaki Y; Noguchi S
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):823-7. PubMed ID: 19034512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
    Jeong YJ; Park YS; Kwon HJ; Shin IH; Bong JG; Park SH
    J Altern Complement Med; 2013 Aug; 19(8):690-6. PubMed ID: 23383974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.